|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Thermally evaporated thin films of SnS for application in solar cell devices显示文摘 | Robert W. Miles Ogah E. Ogah Guillaume Zoppi Ian Forbes | 2009 | Thin Solid Films2009，，17： | 2 |
| 2 | Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford显示文摘BACKGROUND Vedolizumab(VDZ),a humanised monoclonal antibody that selectively inhibits alpha4-beta7 integrins is approved for use in adult moderate to severe ulcerative colitis(UC)patients.AIM To assess the efficacy and safety of VDZ in the real-world management of UC in a large multicenter cohort involving two countries and to identify predictors of achieving remission.METHODS A retrospective review of Australian and Oxford,United Kingdom data for UC patients.Clinical response at 3 mo,endoscopic remission at 6 mo and clinical remission at 3,6 and 12 mo were assessed.Cox regression models and Kaplan Meier curves were performed to assess the time to remission,time to failure and the covariates influencing them.Safety outcomes were recorded.RESULTS Three hundred and three UC patients from 14 centres in Australia and United Kingdom,[60%n=182,anti-TNF naïve]were included.The clinical response was 79%at 3 mo with more Australian patients achieving clinical response compared to Oxford(83%vs 70%P=0.01).Clinical remission for all patients was 56%,62%and 60%at 3,6 and 12 mo respectively.Anti-TNF naive patients were more likely to achieve remission than exposed patients at all the time points(3 mo 66%vs 40%P<0.001,6 mo 73%vs 46%P<0.001,12 mo 66%vs 51%P=0.03).More Australian patients achieved endoscopic remission at 6 mo compared to Oxford(69%vs 43%P=0.01).On multi-variate analysis,anti-TNF naïve patients were 1.8(95%CI:1.3-2.3)times more likely to achieve remission than anti-TNF exposed(P<0.001).32 patients(11%)had colectomy by 12 mo.CONCLUSION VDZ was safe and effective with 60%of UC patients achieving clinical remission at 12 mo and prior anti-TNF exposure influenced this outcome. | Samba Siva Reddy Pulusu Ashish Srinivasan Krupa Krishnaprasad Daniel Cheng Jakob Begun CharlotteKeung Daniel Van Langenberg Lena Thin Tamara Mogilevski Peter De Cruz Graham Radford-Smith Emma Flanagan Sally Bell Soleiman Kashkooli Miles Sparrow Simon Ghaly Peter Bampton Elise Sawyer Susan Connor Quart-ul-ain Rizvi Jane M Andrews Gillian Mahy Paola Chivers Simon Travis Ian Craig Lawrance | 2020 | World Journal of Gastroenterology2020，26，30： | 2 |
| 3 | Standards, Selection and Variety : An Evolutionary Approach 显示文摘 | Metcalfe J S Miles Ian | 1994 | Information Economics and Policy1994，6，12： | 1 |
| 4 | Services in the new industrial economy显示文摘 | Miles Ian | 1993 | Futures1993，25，6： | 1 |
| 5 | 925j Optimising post-operative Crohn’s disease management: best drug therapy alone versus colonoscopic monitoring with treatment step-up. The POCER study.显示文摘 | Peter De Cruz Michael A. Kamm Amy L. Hamilton Kathryn J. Ritchie Soula Krejany Alexandra Gorelik Danny Liew Lani Prideaux Ian C. Lawrance Jane M. Andrews Peter A. Bampton Miles Sparrow Timothy H. Florin Peter R. Gibson Henry Debinski Richard B. Gearry Fin | 2013 | Gastroenterology2013，，5： | 1 |
| 6 | Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer显示文摘 | Valentina Guarneri David Miles Nicholas Robert Véronique Diéras John Glaspy Ian Smith Christoph Thomssen Laura Biganzoli Tanya Taran PierFranco Conte | 2010 | Breast Cancer Research and Treatment2010，，1： | 1 |
| 7 | Services innovation: Coming of age in the knowledge-based Economy 显示文摘 | Ian Miles | 2000 | International Journal of Innovation Management2000，4，： | 1 |
| 8 | Knowledge intensive business services: prospects and policies显示文摘 | Ian Miles | 2005 | foresight2005，，6： | 1 |
| 9 | Western body mass indices need not compromise outcomes after modified D2 gastrectomy for carcinoma显示文摘 | Jonathan D. Barry Guy R.J.C. Blackshaw Paul Edwards Wyn G. Lewis Paula Murphy Ilias Hodzovic Ian W. Thompson Miles C. Allison | 2003 | Gastric Cancer2003，，2： | 1 |
| 10 | Standardisation and particularisation in services: evidence from Germany显示文摘 | Bruce S Tether Christiane Hipp Ian Miles | 2001 | Research Policy2001，，7： | 1 |
| 11 | Service innovation in manufacturing firms:Evidence from Spain,显示文摘 | Llu??s Santamar??a a n Mar??a Jesu?s Nieto b Ian Miles c | 2012 | Technovation2012，32，： | 1 |
| 12 | Services innovation 显示文摘 | IAN MILES | 2000 | International Journal of Innovation Management Volume 4 Number 4 December 20002000，，： | 1 |
| 13 | Western body mass indices need not compromise outcomes after modified D2 gastrectomy for carcinoma显示文摘 | Jonathan D. Barry Guy R.J.C. Blackshaw Paul Edwards Wyn G. Lewis Paula Murphy Ilias Hodzovic Ian W. Thompson Miles C. Allison | 2003 | Gastric Cancer2003，，2： | 1 |
| 14 | The development of technology foresight: a review显示文摘 | IAN MILES | 2010 | Technological Forecasting & Social Change2010，，77： | 1 |
| 15 | Knowledge-intensive business services:users,carriers and sources of innovation显示文摘 | Miles Ian Kastrinos N Flanagan K Bilderbeek R Hertog P Huntink W Bouman M | 1995 | Innovation Programmer1995，，3： | 1 |
| 16 | Two decades of research on innovation in services: Which place for public services?显示文摘 | Faridah Djellal Fa?z Gallouj Ian Miles | 2013 | Structural Change and Economic Dynamics2013，，： | 1 |
| 17 | Eliciting experts' knowledge: a comparison of two methods显示文摘 | Fabiana Scapolo Ian Miles | 2006 | Technological Forecasting and Social Change2006，73，6： | 1 |
| 18 | Service Innovation in Manufacturing Firms:Evidence from Spain显示文摘 | Llu's Santamar'a Mar'a Jesu's Nieto Ian Miles | 2012 | Technovation2012，32，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员